HIF antibody selection: a protein lost within minutes of reoxygenation

Handling a target that disappears

1. Lyse inside the chamber, or accept the loss. The hypoxia factor is hydroxylated and degraded rapidly once oxygen is available, so plates taken to a bench lose most of the signal before lysis. Lysing inside the hypoxia chamber, or working fast on ice with the lysis buffer already prepared, is the difference between a band and nothing.
2. Use a proteasome inhibitor arm as the positive control. Blocking degradation stabilises the factor and gives a strong band that shows the antibody and the blot work. It also proves that a missing band in the experimental arm is biology rather than handling.
3. Know that a nuclear fraction reports the active pool. The factor acts in the nucleus and the whole-cell level includes protein on its way to destruction. Fractionating, or imaging a nuclear signal per cell, reports the pool that is doing something.
4. Treat the transporters as multipass membrane proteins. Amino acid and other solute transporters aggregate when boiled and need a detergent that keeps the epitope. Denature at a lower temperature, prepare membranes rather than whole lysate, and use a genetic negative because background is high.
5. Use a modification-aware reagent where the target is a modifier. Enzymes that add a sugar or another modification are read through their substrates as much as through their own level, so a total antibody tells you the enzyme is present while a substrate-modification antibody tells you it is working.

Chemical hypoxia mimetics and their limits

Compounds that stabilise the factor by inhibiting its hydroxylases are convenient and are not hypoxia: they stabilise the protein without changing oxygen tension, so the rest of the cell's response differs. Use them as controls and be explicit about the distinction.

Where the biology of low oxygen matters rather than the factor alone, a real chamber with measured oxygen tension is the experiment, and the tension should be recorded rather than assumed from the setting.

Downstream targets as the honest readout

Transcriptional targets of the pathway accumulate over hours and are far easier to measure than the factor itself. Where the question is whether the pathway ran, a target transcript or protein is more robust than chasing a protein that disappears.

Measuring both, with the factor as the immediate readout and a target as the durable one, is what makes a hypoxia experiment convincing rather than fragile.

Iron handling targets such as a transferrin antibody or a transferrin receptor antibody, and oxidative proteins

Proteins that store or transport iron respond quickly to cellular state and are regulated at translation as well as transcription. A change in protein with no change in message is expected here rather than anomalous, which is worth knowing before it is written up as a surprise.

Sample handling dominates: oxidation during preparation changes both the protein and any downstream marker of oxidative damage. Fix the collection protocol first and then compare conditions, because a difference in handling looks exactly like a difference in biology and nothing in the analysis can separate them afterwards.

An MDA antibody and other adduct markers report a chemistry, not a time

Antibodies raised against adducts formed when lipids or proteins are damaged report that a chemistry occurred. They cannot say when, how quickly or whether it mattered, and the adducts accumulate during sample handling as readily as in the tissue.

Treat any difference smaller than your handling variation as unproven, include a sample processed identically and known to be unaffected, and keep collection identical across conditions. These reagents are informative when the protocol is controlled and misleading when it is not.

Targets with a disputed reagent history

A few enzymes in this area have a published history of antibodies that later proved non-specific, and results built on them were withdrawn. Where a target has that reputation, the field's own guidance is usually explicit about which reagents and which controls are acceptable.

Following it is cheaper than arguing with a reviewer. Where no such guidance exists, the fallback is the same as everywhere else in this catalogue: a genetic control in your own hands, in your own application, with the lot recorded.

Cytosolic and mitochondrial forms of one activity

Several metabolic enzymes exist as a cytosolic and a mitochondrial isoform encoded by different genes, with different regulation and different biology. A whole-cell lysate merges them, and an antibody may see one or both.

If the isoform matters, fractionate and show the fractionation worked with a marker for each compartment. Without that control the result cannot distinguish the two, however clean the band looks.

An fabp4 antibody and an fabp5 antibody across the family

The fatty acid binding proteins are a family of small cytoplasmic carriers with tissue restricted expression, so an fabp4 antibody and an fabp5 antibody both need cross reactivity data against the relatives expressed in the same tissue, and the small size means a high percentage gel resolves them best. FABP4 is also secreted and measured in plasma, which is a different assay from the blot.

An fabp7 antibody and the brain member

FABP7 is the brain member of the same family and is used as a radial glial and astrocyte marker, so an fabp7 antibody is interpreted by the cell type rather than by the pathway, and specificity against the other family members is what makes that identification safe. It is cytoplasmic and fills processes, which is the pattern rather than a punctate signal.

Common questions

Why does my hif antibody show no band from hypoxic cells?

The protein is degraded within minutes of reoxygenation, so it is usually lost between the chamber and the bench. Lyse inside the chamber, or work fast and cold, and run a proteasome inhibitor arm as a positive control.

What proves the blot would have worked?

A proteasome inhibitor arm. Blocking degradation stabilises the protein and gives a strong band, which shows the reagent and the transfer are fine and that the experimental result is biology.

Why do my SLC1A5 antibody and SLC7A11 antibody blots look like nothing?

Multipass transporters aggregate when boiled and stay in the well. Denature at thirty seven or seventy degrees, prepare membranes rather than whole lysate, and use a knockdown as the specificity control.

Should the hypoxia factor be measured in the nucleus?

Where the question is about activity, yes. The whole-cell pool includes protein destined for degradation, so a nuclear fraction or a per-cell nuclear intensity is a better proxy for the active pool.

Why does my membrane enzyme vanish from the gel?

Standard lysis and heating aggregate multi-pass membrane proteins so that they never enter the gel. Use the gentler solubilisation the validation used, avoid boiling, and enrich the membrane fraction.

Browse by service class

• Compare Gene synthesis on advertised prices